Filip Dubovsky
Chief Tech/Sci/R&D Officer chez NOVAVAX, INC.
Fortune : 318 410 $ au 31/03/2024
Profil
Actuellement, Filip Dubovsky occupe le poste de directeur médical et de vice-président exécutif chez Novavax, Inc. Il est également membre du conseil d'administration de l'Albert B. Sabin Vaccine Institute, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVAVAX, INC.
0,05% | 10/03/2024 | 66 613 ( 0,05% ) | 318 410 $ | 31/03/2024 |
Postes actifs de Filip Dubovsky
| Sociétés | Poste | Début |
|---|---|---|
| NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | 17/06/2020 |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Director/Board Member | - |
Anciens postes connus de Filip Dubovsky
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Formation de Filip Dubovsky
| The Johns Hopkins University | Undergraduate Degree |
| The University of Alabama | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| NOVAVAX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
